Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
J Mol Biol ; 367(2): 395-408, 2007 Mar 23.
Artículo en Inglés | MEDLINE | ID: mdl-17258232

RESUMEN

Hepatocyte growth factor/scatter factor (HGF/SF), the ligand for the receptor tyrosine kinase encoded by the c-Met proto-oncogene, is a multidomain protein structurally related to the pro-enzyme plasminogen and with major roles in development, tissue regeneration and cancer. We have expressed the N-terminal (N) domain, the four kringle domains (K1 to K4) and the serine proteinase homology domain (SP) of HGF/SF individually in yeast or mammalian cells and studied their ability to: (i) bind the Met receptor as well as heparan sulphate and dermatan sulphate co-receptors, (ii) activate Met in target cells and, (iii) map their binding sites onto the beta-propeller domain of Met. The N, K1 and SP domains bound Met directly with comparable affinities (K(d)=2.4, 3.3 and 1.4 microM). The same domains also bound heparin with decreasing affinities (N>K1>>SP) but only the N domain bound dermatan sulphate. Three kringle domains (K1, K2 and K4) displayed agonistic activity on target cells. In contrast, the N and SP domains, although capable of Met binding, displayed no or little activity. Further, cross-linking experiments demonstrated that both the N domain and kringles 1-2 bind the beta-chain moiety (amino acid residues 308-514) of the Met beta-propeller. In summary, the K1, K2 and K4 domains of HGF/SF are sufficient for Met activation, whereas the N and SP domains are not, although the latter domains contribute additional binding sites necessary for receptor activation by full length HGF/SF. The results provide new insights into the structure/function of HGF/SF and a basis for engineering the N and K1 domains as receptor antagonists for cancer therapy.


Asunto(s)
Dermatán Sulfato/metabolismo , Heparitina Sulfato/metabolismo , Factor de Crecimiento de Hepatocito/fisiología , Proteínas Proto-Oncogénicas c-met/metabolismo , Animales , Sitios de Unión , Línea Celular , Movimiento Celular , Cricetinae , Cricetulus , Perros , Ensayo de Cambio de Movilidad Electroforética , Activación Enzimática , Quinasas MAP Reguladas por Señal Extracelular/metabolismo , Factor de Crecimiento de Hepatocito/genética , Factor de Crecimiento de Hepatocito/metabolismo , Humanos , Kringles , Ratones , Mutación , Fosforilación , Pichia , Unión Proteica , Estructura Terciaria de Proteína , Proto-Oncogenes Mas , Serina Endopeptidasas/genética , Relación Estructura-Actividad
2.
J Mol Biol ; 340(4): 797-808, 2004 Jul 16.
Artículo en Inglés | MEDLINE | ID: mdl-15223321

RESUMEN

EmrE is a multidrug transporter that utilises the proton gradient across bacterial cell membranes to pump hydrophobic cationic toxins out of the cell. The structure of EmrE is very unusual, because it is an asymmetric homodimer containing eight alpha-helices, six of which form the substrate-binding chamber and translocation pathway. Despite this structural information, the precise oligomeric order of EmrE in both the detergent-solubilised state and in vivo is unclear, although it must contain an even number of subunits to satisfy substrate-binding data. We have studied the oligomeric state of EmrE, purified in a functional form in dodecylmaltoside, by high-resolution size-exclusion chromatography (hrSEC) and by analytical ultracentrifugation. The data from equilibrium analytical ultracentrifugation were analysed using a measured density increment for the EmrE-lipid-detergent complex, which showed that the purified EmrE was predominantly a dimer. This value was consistent with the apparent mass for the EmrE-lipid-detergent complex (137 kDa) determined by hrSEC. EmrE was purified under different conditions using minimal concentrations of dodecylmaltoside, which would have maintained the structure of any putative higher oligomeric states: this EmrE preparation had an apparent mass of 206 kDa by hrSEC and equilibrium analytical ultracentrifugation showed unequivocally that EmrE was a dimer, although it was associated with a much larger mass of phospholipid. In addition, the effect of the substrate tetraphenylphosphonium on the oligomeric state was also analysed for both preparations of EmrE; velocity analytical ultracentrifugation showed that the substrate had no effect on the oligomeric state. Therefore, in the detergent dodecylmaltoside and under conditions where the protein is fully competent for substrate binding, EmrE is dimeric and there is no evidence from our data to suggest higher oligomeric states. These observations are discussed in relation to the recently published structures of EmrE from two- and three-dimensional crystals.


Asunto(s)
Detergentes/farmacología , Proteínas de Escherichia coli/química , Proteínas de Escherichia coli/aislamiento & purificación , Proteínas de Transporte de Membrana/química , Proteínas de Transporte de Membrana/aislamiento & purificación , Aminoácidos/análisis , Calibración/normas , Cromatografía por Intercambio Iónico , Cromatografía en Capa Delgada , Colorimetría , Dimerización , Farmacorresistencia Microbiana , Proteínas de Escherichia coli/metabolismo , Glucósidos/farmacología , Lípidos/análisis , Espectrometría de Masas , Proteínas de Transporte de Membrana/metabolismo , Micelas , Peso Molecular , Fosfolípidos/normas , Solubilidad , Ultracentrifugación
3.
FEBS Lett ; 2(4): 239-241, 1969 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-11946322
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA